Search Results

Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trials.

• Authors : Holten K; ARCTIC REWIND study group

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/diagnosis ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use

• Source: RMD open [RMD Open] 2024 Sep 05; Vol. 10 (3). Date of Electronic Publication: 2024 Sep 05.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium:

Record details

Safety and efficacy of colchicine in crystal-induced arthritis flare in 54 patients with severe chronic kidney disease.

• Authors : Bausson J; Service de Pharmacie-Stérilisation, Hôpitaux universitaires de Strasbourg, Strasbourg, France.; Keller N

Subjects: Gout*/Gout*/Gout*/complications ; Gout*/Gout*/Gout*/drug therapy ; Chondrocalcinosis*/Chondrocalcinosis*/Chondrocalcinosis*/chemically induced

• Source: RMD open [RMD Open] 2024 Jan 31; Vol. 10 (1). Date of Electronic Publication: 2024 Jan 31.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium:

Record details

Lifestyle factors predict gout outcomes: Results from the NOR-Gout longitudinal 2-year treat-to-target study.

• Authors : Uhlig T; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway .; University of Oslo, Oslo, Norway.

Subjects: Gout*/Gout*/Gout*/drug therapy ; Gout*/Gout*/Gout*/epidemiology; Humans

• Source: RMD open [RMD Open] 2023 Dec 01; Vol. 9 (4). Date of Electronic Publication: 2023 Dec 01.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium:

Record details

Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I/II trial.

• Authors : Wang H; Department of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.; Li T

Subjects: Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/complications ; Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/Lupus Erythematosus, Systemic*/drug therapy ; Lupus Nephritis*/Lupus Nephritis*/Lupus Nephritis*/complications

• Source: RMD open [RMD Open] 2022 Oct; Vol. 8 (2).Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Print Cited Medium:

Record details

A longitudinal observational study of back pain incidence, risk factors and occupational physical activity in Swedish marine trainees.

• Authors : Monnier, Andreas; Larsson, Helena; Nero, Håkan

• Source: BMJ Open; May2019, Vol. 9 Issue 5, p1-14, 14p

Record details

Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flares.

• Authors : Carubbi F; Department of Life, Health & Environmental Sciences and Internal Medicine and Nephrology Unit, Department of Medicine, University of L'Aquila and ASL Avezzano-Sulmona-L'Aquila, San Salvatore Hospital, L'Aquila, Italy .; Alunno A

Subjects: Autoimmune Diseases*/Autoimmune Diseases*/Autoimmune Diseases*/chemically induced ; Autoimmune Diseases*/Autoimmune Diseases*/Autoimmune Diseases*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/prevention & control

• Source: RMD open [RMD Open] 2022 Sep; Vol. 8 (2).Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Print Cited Medium:

Record details

Clinical and cost-effectiveness of progressive exercise compared with best practice advice, with or without corticosteroid injection, for the treatment of rotator cuff disorders: protocol for a 2×2 factorial randomised controlled trial (the GRASP trial)

• Authors : Hopewell, Sally; Keene, David J.; Schlüssel, Michael Maia

• Source: BMJ Open; Jul2017, Vol. 7 Issue 7, p1-10, 10p

Record details

Abstracts Accepted for Publication.

• Source: Annals of the Rheumatic Diseases; 2016 Supplement 2, Vol. 75, p897-1263, 298p, 7 Color Photographs, 2 Black and White Photographs, 17 Diagrams, 218 Charts, 106 Graphs

Record details

12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target.

• Authors : Uhlig T; Rheumatology, Diakonhjemmet Hospital, Oslo, Norway .; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Subjects: Gout*/Gout*/Gout*/drug therapy ; Uric Acid*; Female

• Source: RMD open [RMD Open] 2021 Mar; Vol. 7 (1).Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Print Cited Medium:

Record details

DMARD-free remission as novel treatment target in rheumatoid arthritis: A systematic literature review of achievability and sustainability.

• Authors : Verstappen M; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands .; van Mulligen E

Subjects: Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*therapeutic use ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy ; Induction Chemotherapy/Induction Chemotherapy/Induction Chemotherapy/*methods

• Source: RMD open [RMD Open] 2020 May; Vol. 6 (1).Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Print Cited Medium:

Record details